)
Dexcom (DXCM) investor relations material
Dexcom 47th Annual Raymond James Institutional Investor Conference summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Key strategic priorities and leadership changes
Focus on being the premier glucose sensing solution, enhancing customer experience, and expanding internationally.
Jake Leach, with 21 years at the company, has become CEO, succeeding Kevin Sayer.
Emphasis on scalable operations to support global growth and manufacturing expansion.
Mission remains personal, with many employees using the product themselves.
Market landscape and growth opportunities
Diabetes prevalence is rising, with 600 million diagnosed globally, projected to reach 853 million by 2050.
Only 2% of the diabetes population currently uses CGM, indicating significant untapped market potential.
Coverage for CGM has expanded, but awareness and adoption lag, especially among those already covered.
Type 2 basal and non-insulin segments present major growth opportunities due to low penetration.
Product innovation and technology advancements
Launched Dexcom G7 15 Day system, improving wear time and efficiency.
SmartBasal enables remote insulin titration with physician oversight, rolling out in select clinics.
Enhanced digital experience with My Dexcom account and AI-driven support tools.
G8 sensor to launch soon, promising highest accuracy and smallest form factor.
- Q4 revenue up 13% with margin gains; 2026 outlook strong amid global expansion and innovation.DXCM
Q4 202513 Feb 2026 - Revenue and user growth accelerate as innovation and global access expand in diabetes care.DXCM
Investor presentation12 Feb 2026 - Q2 revenue up 15% to $1.004B; 2024 guidance cut, $750M buyback announced.DXCM
Q2 20242 Feb 2026 - Stelo, an OTC CGM for non-insulin users, launches August 2024, expanding global reach.DXCM
The 44th Annual William Blair Growth Stock Conference1 Feb 2026 - Strong CGM market growth expected as execution improves and new products like Stelo gain traction.DXCM
2024 Wells Fargo Healthcare Conference22 Jan 2026 - Q3 2024 saw 3% organic revenue growth, strong international gains, and rapid Stelo adoption.DXCM
Q3 202418 Jan 2026 - Record growth, innovation, and expanded access drive strong 2026 outlook.DXCM
44th Annual J.P. Morgan Healthcare Conference12 Jan 2026 - Broader CGM coverage, new products, and global growth drive a strong 2025 outlook.DXCM
43rd Annual J.P. Morgan Healthcare Conference 202510 Jan 2026 - Q4 revenue up 8%, customer base up 25%, and 2025 guidance targets 14% growth and margin gains.DXCM
Q4 20248 Jan 2026
Next Dexcom earnings date
Next Dexcom earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
Frequently asked questions
Explore our global coverage
)
)